2016 Partnerships in Clinical trials (PCT) part of Boston Biotech Week taking place from 5th – 7th October is your chance to learn about the Biologic opportunity!As per current reports in public domain a huge market opportunity lies ahead for Bio-silimar developers, with Biologics with sales worth $ 100 Billion going off patent by 2020*
Over 3700 developers are in this race to develop Biosimilar / Biobetter.*
Over 1357 Biosimilar / Biobetter in pipeline*
The demand for comparator drug has been estimated as 500,000 units for phase I trial alone!!!
Can US markets alone supply this quantity to the developers ?
Have you arranged your comparator drug source yet ?
Don’t let the humble comparator drug derail for Billion dollar dreams !
“Little known fact about comparator sourcing from Emerging markets” by Dr. Piyush Gupta on 5th October at the 2016 PCT at Emerging Market Session @ 3:30 pm.
Read the white paper
Comparator sourcing from Emerging Markets and associated cost savings.
Meet Us
Meet our representative at the PCT loft, Booth 21.
Email us for an appointment: [email protected]